Abstract
Pharmaceutical Value (pValue), a center of excellence funded by PhRMA Foundation in novel value assessment, partnered with the Cancer Support Community to gain patient insights into the importance of value assessment criteria. Prior to developing quantitative multicriteria decision analysis (MCDA) tools for value assessment interpretation, we conducted preliminary evidence synthesis and generation exercises to identify and understand the importance of value criteria. The objective of this study was to engage cancer patients to elicit the criteria that are most important toward their judgements related to the value of therapies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
